AW
KRYS icon

Avion Wealth’s Krystal Biotech KRYS Stock Holding History

Avion Wealth’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1K Hold
6
– – ﹤0.01% 1256
2026
Q2 		$2K Hold
6
– – ﹤0.01% 1079
2026
Q1 		$1K Hold
6
– – ﹤0.01% 1073
2025
Q4 		$1K Buy
6
+2
+50% +$421 ﹤0.01% 1066
2025
Q3 		$0 Hold
4
– – ﹤0.01% 1396
2025
Q2 		$0 Buy
+4
New +$588 ﹤0.01% 1407
2024
Q4 		– Sell
-3
Closed – – 1156
2024
Q3 		$0 Buy
+3
New +$578 ﹤0.01% 1188

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Avion Wealth's KRYS Position: Q3 2026 in Review

Avion Wealth held its Krystal Biotech (KRYS) position steady in Q3 2026 at 6 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Avion Wealth first reported a position in KRYS in Q3 2024 and has held it in 7 quarters since. The position peaked at $2K in Q2 2026. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Avion Wealth held 6 shares of Krystal Biotech worth $1K as of Q3 2026.
  • Avion Wealth left its Krystal Biotech share count unchanged in Q3 2026.
  • Krystal Biotech made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #1256 holding.
  • Avion Wealth first reported a position in Krystal Biotech in Q3 2024 and has held it in 7 quarters since.
  • Avion Wealth's Krystal Biotech position peaked at $2K in Q2 2026.
  • 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.